Maria Cosentino, DPM
Foot Surgery · Manhattan, KSNPI 1629508833
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,612 of the $2,111 with a category attached, or 76.4%. 14 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 52.5% of the total.
Across 26 payments — averaging $81.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$1K
- Paragon 28, Inc.$651
- Smith+Nephew$96
- Mimedx Group, Inc.$30
- Medshape, Inc.$28
- Reprise Biomedical, Inc.$27
- plus $170 from 8 others
What the payments were for
- Travel & lodging$1,61276%
- Food & beverage$49924%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 7 | $1,109 |
| Paragon 28, Inc. | 1 | $651 |
| Smith+Nephew | 5 | $96 |
| Mimedx Group, Inc. | 2 | $30 |
| Medshape, Inc. | 1 | $28 |
| Reprise Biomedical, Inc. | 2 | $27 |
| AbbVie | 1 | $27 |
| Integra Lifesciences Corporation | 1 | $27 |
| Averitas Pharma Inc. | 1 | $26 |
| Kerecis Limited | 1 | $20 |
| KCI USA, Inc. | 1 | $19 |
| Organogenesis Inc. | 1 | $19 |
| Stryker | 1 | $16 |
| Melinta Therapeutics, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LAPIPLASTY SYSTEM 1$961
- GORILLA$651
How this compares
Too few foot surgery providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 33 | $740 |
| Triamcinolone Acetonide | 30 | $446 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $244 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $50 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Manhattan
- Priti LakhaniTopeka$208K
- Richard BurkeyGreat Bend$8K
- Timothy GateleyTopeka$2K
- Steven GeduldigOlathe$329
- Holly KorgesLenexa$299
- Mitchell DorrisShawnee Mission$296
- Todd VanwyngardenShawnee Mission$282
- Michael NachlasShawnee Mission$84
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.